bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital
June 2, 2025
Genprex Receives U.S. FDA Fast Track Designation for REQORSA(TM) Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer
January 3, 2022
Related Post
-
-
Coherus Completes Strategic Transformation to Coherus Oncology, Focusing Exclusively on Innovative Cancer Therapeutics
May 30, 2025
-
Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15
May 21, 2025
-
Rani Therapeutics Announces Research Agreement with Chugai
May 19, 2025